| |
|
| |
| DETAILS |
|
George Scangos, PhD, has served as Vir Biotechnology's president & CEO & as a member of its board of directors since January 2017. He previously served as CEO & as a member of the board of directors of Biogen, a publicly traded biopharmaceutical company focused on treating neurological diseases, & also held roles as president & CEO of Exelixis, president of Bayer Biotechnology, & professor of biology at Johns Hopkins University.
Dr. Scangos currently serves on the Board of Trustees of Cornell University & the Board of Overseers of the University of California, San Francisco. Dr. Scangos received his BA in biology from Cornell University & a PhD in microbiology from the University of Massachusetts.
This appearance by George Scangos is part of the Entrepreneurial Thought Leaders series. Join us live as we bring founders, investors & industry influencers to center stage & invite them to share what it takes to become a disruptor.
|
|
|
|
|
|
|
|
